Century Therapeutics (IPSC) Return on Sales (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• On a quarterly basis, Return on Sales rose 9.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 19.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 19.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for IPSC reached as high as 0.01% in Q1 2025 and fell as low as 3.36% in Q2 2023.
• Historically, Return on Sales has averaged 0.61% across 4 years, with a median of 0.28% in 2024.
• Across the five-year window, Return on Sales slumped 314 bps in 2023 and jumped 296 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.61% in 2022, then sank by 142 bps to 1.47% in 2023, then surged by 94 bps to 0.09% in 2024, then jumped by 100 bps to 0.0% in 2025.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.